Lasmiditan (200 Mg and 100 Mg) Compared to Placebo for Acute Treatment of Migraine

被引：0
|
作者：
Kuca, B. [1 ]
Wietecha, L. [2 ]
Berg, P. [2 ]
Aurora, S. K. [2 ]
机构：
[1] CoLucid Pharmaceut Inc, Cambridge, MA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
HEADACHE | 2017年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IOR-11LB
引用
收藏
页码：1311 / 1312
页数：2
相关论文
共 50 条
  • [1] Lasmiditan (200 mg and 100 mg) compared to placebo for acute treatment of migraine
    Kuca, Bernice
    Wietecha, Linda
    Berg, Paul H.
    Aurora, Sheena K.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [2] Exploration of Lasmiditan 200 mg Versus 100 mg for the Treatment of Migraine: A Meta-analysis Based on Aggregate Data
    Wang, Ting
    Feng, Yimo
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (02) : 44 - 47
  • [3] Placebo-controlled trial with tolfenamic acid 200 mg and sumatriptan 100 mg in acute treatment of migraine.
    Rasmussen, MJK
    Hansen, AW
    Schmidt-Hansen, PT
    Hansen, PE
    Lademann, A
    Hinge, HH
    CEPHALALGIA, 1999, 19 (04) : 318 - 319
  • [4] Comparison of Lasmiditan 200 mg Versus 100 mg for Migraine Patients: A Meta-analysis of Randomized Controlled Studies
    Zhong, Chuan
    Zhang, Xuanqin
    Qin, Guoyong
    Wu, Jixiang
    Tian, Yongpan
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (01) : 1 - 6
  • [5] DICLOFENAC-K (50 AND 100 MG) AND PLACEBO IN THE ACUTE TREATMENT OF MIGRAINE
    DAHLOF, C
    BJORKMAN, R
    CEPHALALGIA, 1993, 13 (02) : 117 - 123
  • [6] Phase 3 Study (SPARTAN) of Lasmiditan Compared to Placebo for Acute Treatment of Migraine
    Wietecha, Linda A.
    Kuca, Bernice
    Case, Michael G.
    Selzler, Katherine J.
    Aurora, Sheena K.
    CEPHALALGIA, 2017, 37 : 367 - 368
  • [7] PHASE 3 STUDY (SPARTAN) OF LASMIDITAN COMPARED TO PLACEBO FOR ACUTE TREATMENT OF MIGRAINE
    Wietecha, L. A.
    Kuca, B.
    Case, M. G.
    Selzler, K. J.
    Aurora, S.
    CEPHALALGIA, 2018, 38 : 57 - 58
  • [8] Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan Compared to Placebo for Acute Treatment of Migraine
    Wietecha, L.
    Kuca, B.
    Asafu-Adjei, J.
    Aurora, S.
    HEADACHE, 2018, 58 : 73 - 73
  • [9] Phase 3 studies (SAMURAI, SPARTAN) of lasmiditan compared to placebo for acute treatment of migraine
    Wietecha, Linda A.
    Kuca, Bernice
    Asafu-Adjei, Josephine
    Aurora, Sheena K.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [10] Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan Compared to Placebo for Acute Treatment of Migraine
    Wietecha, Linda A.
    Kuca, Bernice
    Asafu-Adjei, Josephine
    Aurora, Sheena K.
    NEUROLOGY, 2018, 90
12345